“We never see ourselves as others see us.”
– Oliver Hardy

Weight Loss & Obesity

See also:






References & Resources

Program – Body Composition Analysis (BCA)

  1. Body Composition Analysis – Patient Preparation handout
  2. Measurement of visceral fat by abdominal bioelectrical impedance analysis is beneficial in medical checkup. – PubMed – NCBI
  3. The clinical importance of visceral adiposity – a critical review of methods for visceral adipose tissue analysis – 2012
  4. The use of bioelectrical impedance to detect excess visceral and subcutaneous fat – 2007


Program – NLAL Lipolysis

NLAL Lipolysis – Handouts

  1. NLAL Lipolysis
  2. NLAL – Patient Treatment Info

NLAL Lipolysis – References

  1. Fat Liquefaction – Effect of Low-Level Laser Energy on Adipose Tissue
  2. Application of low-level laser therapy for noninvasive body contouring. – PubMed – NCBI
  3. Body contouring using 635-nm low level laser therapy. – PubMed – NCBI
  4. Efficacy of low-level laser therapy for body contouring and spot fat reduction. – PubMed – NCBI
  5. Independent evaluation of low-level laser therapy at 635 nm for non-invasive body contouring of the waist, hips, and thighs. – PubMed – NCBI
  6. Low-level laser therapy as a non-invasive approach for body contouring: a randomized, controlled study. – PubMed – NCBI


  1. Chia Seeds
  2. Pistachios
  3. Fiber

Weight Loss

CAM – Supplements for weight loss:

  1. Multi-Nutrient Supplements
  2. NRF2 Activators
  3. CoQ10
  4. Nicotinamide Riboside (NR)

Appetite Suppressants

Appetite Suppressants –  CAM

  1. Appe-control and Hunger Block


Appetite Suppressants – Prescription Medication List

  1. Adipex (Phentermine)
  2. Belviq (Lorcaserin)
  3. Bupropion
  4. Contrave (Bupropion/Naltrexone)
  5. Invokana (Canagliflozin)
  6. Naltrexone
  7. Orlistat (Xenical, Alli)
  8. Qsymia (Phentermine and Topiramate)
  9. Saxenda (Liraglutide)
  10. Topamax (Topiramate)
  11. Wegovy (Semaglutide)

Appetite Suppressants – Prescription Medication References

Wegovy (Semaglutide)

  1.  Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity – PMC – 2021
  2. Singh G, et al. J Investig Med 2022;70-5–13. doi-10.1136 jim-2021-0019525 Review Wegovy (semaglutide)- a new weight loss drug for chronic weight management – 2022
  3. Once-Weekly Semaglutide in Adults with Overweight or Obesity – 2021
  4. Once-Weekly Semaglutide in Adults with Overweight or Obesity – PubMed – 2021


Eating Behavior

Eating Behavior – Emotional Eating

  1. Emotional Eating

Eating Behavior – ExternalEating Cues

  1. External Eating Cues

Eating Behavior – Fasting

  1. Calorie restriction increases life span: a molecular mechanism. – PubMed – NCBICalorie restriction increases muscle mitochondrial biogenesis in healthy humans. – 2007
  2. A double-blind, placebo-controlled test of 2 d of calorie deprivation – effects on cognition, activity, sleep, and interstitial glucose concentrations – 2008
  3. Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects – 2015

Maladaptive Eating – Cravings, Binging & Addictive-like Eating

Maladaptive Eating – Cravings

Cravings – Overview

  1. Food craving – new contributions on its assessment, moderators, and consequences – 2015
  2. Pickles and ice cream! Food cravings in pregnancy – 2014
  3. Relationship of cravings with weight loss and hunger – Results from a 6 month worksite weight loss intervention – 2013
  4. How Relevant is Food Craving to Obesity and Its Treatment? – 2014

Cravings – Treatment

Cravings Treatment –  CAM Supplements

  1. Quercetin
  1. Synaptamine

Maladaptive Eating – Binge Eating Disoder (BED)

BED – Overview

  1. Binge Eating Disorder – Recognition, Diagnosis, and Treatment

BED – Dopamine </sp an>

  1. Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. – PubMed – NCBI
  2. Dopamine for “Wanting” and Opioids for “Liking” – A Comparison of Obese Adults With and Without Binge Eating-2009


BED – Treatment

BED – Treatment, Overview

  1. Current and Emerging Drug Treatments for Binge Eating Disorder – 2014
  2. Pharmacological management of binge eating disorder – current and emerging treatment options

BED -Treatment, Bupropion

  1. Bupropion for Overweight Women with Binge Eating Disorder – Randomized Double-blind Placebo-controlled Trial – 2013

BED -Treatment, Chromium

  1. Chromium Picolinate – Summary
  2. A Double-blind, Randomized Pilot Trial of Chromium Picolinate for Binge Eating Disorder – Results of the Binge Eating and Chromium (BEACh) Study – 2013
  3. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating. – PubMed – NCBI

BED -Treatment, Contrave

  1. Treatment of Binge Eating Disorder in Obesity: Naltrexone: Bupropion Combination Versus Placebo – Full Text View – ClinicalTrials.gov



Obesity – Visceral Fat

Obesity, Visceral Fat – Overviews

  1. Pathophysiology of Human Visceral Obesity – An Update

Obesity, Visceral Fat – Biomarkers

Obesity, Visceral Fat Biomarkers – Adinopectin

  1. The role of fat topology in the risk of disease. – PubMed – NCBI

Obesity, Visceral Fat Biomarkers – IL-6

  1. Metabolic obesity: the paradox between visceral and subcutaneous fat. – PubMed – NCBI

Obesity, Visceral Fat Biomarkers – Hypertriglyceridemia

  1. Hypertriglyceridemic waist – a useful screening phenotype in preventive cardiology? – 2007

Obesity, Visceral Fat – Exercise

  1. Effect of exercise training intensity on abdominal visceral fat and body composition

Obesity, Visceral Fat – Genetics

  1. Genetic and behavioral influences on body fat distribution. – PubMed – NCBI
  2. The genetics of fat distribution – 2014

Obesity, Visceral Fat – Stress

  1. Interleukin-1 beta – a potential link between stress and the development of visceral obesity – 2012


Obesity – Vitamins

Obesity, Vitamins – Overviews

  1. Vitamin status in morbidly obese patients – a cross-sectional study – 2008

Obesity – Vitamin C

Obesity – Vitamin D

  1. Decreased bioavailability of vitamin D in obesity – 2000
  2. Higher visceral fat area increases the risk of vitamin D insufficiency and defic
    iency in Chinese adults – 2015
  3. Obesity and vitamin D 2004
  4. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. – PubMed – NCBI
  5. The Effect Of Vitamin D Supplementation On Serum 25OHD In Thin And Obese Women – 2012
  6. The Longitudinal Association of Vitamin D Serum Concentrations & Adiposity Phenotype – 2013
  7. Vitamin D and Its Relationship with Obesity and Muscle – 2014
  8. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers – 2009
  9. Update on vitamin D – pros and cons – 2015

Obesity – Comorbid Conditions

Obesity – Fatty Liver

  1. The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. – PubMed – NCBI
  2. What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa? – PubMed – NCBI

Obesity – Kidney Disease

  1. Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population


Obesity – Metabolic Syndrome

  1. Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population
  2. Abdominal Obesity and the Metabolic Syndrome – Contribution to Global Cardiometabolic Risk – 2008
  3. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets. – PubMed – NCBI
  4. Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome: Endocrine Reviews: Vol 21, No 6

Obesity – Oxidative Stress

  1. Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. – PubMed – NCBI

Obesity – Sleep Apnea

  1. Visceral fat and respiratory complications – 2004
  2. What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa? – PubMed – NCBI

Educational Resources

Resources for Help

Emphasis on Education


Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.


For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.


Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thous
ands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.


For more information, please contact Accurate Clinic.


Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

Accurate Supplement Prices